Atlas Trials

Zhengzhou University

28 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zhengzhou University

RecordFirmDate
Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma (NCT07299331)Zhengzhou University2026-01-01
ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial (NCT07264894)Zhengzhou University2025-12-31
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation (NCT07117305)Zhengzhou University2025-09-01
Stage-Matched Psychosocial Intervention for Parent Caregivers of Children With Leukemia in Pakistan (NCT07563335)Zhengzhou University2025-06-10
Stepped-Care Support for Children With Leukaemia (NCT07587411)Zhengzhou University2025-06-10
Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma (NCT06956092)Zhengzhou University2025-05-30
Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma (NCT06609304)Zhengzhou University2024-09-30
A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma (NCT06742879)Zhengzhou University2024-05-01
Effect of Educational Program on Parental Stress of Parents of Children With CHD (NCT06172608)Zhengzhou University2024-01-30
Clinical Study of CEP+Dasatinib + Azacytidine in First-line Treatment of. Angioimmunoblastoma Foresight (NCT07046182)Zhengzhou University2023-10-21
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma (NCT05535673)Zhengzhou University2022-09-02
Improving Wellbeing in Older Adults: The Impact of an Active Aging Education Program in Pakistan (NCT05918289)Zhengzhou University2022-08-15
A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma (NCT05506410)Zhengzhou University2022-08-12
Dyadic Interventions to Boost Quality of Life Among Stroke Survivors and Care Partners in Pakistan. (NCT06827093)Zhengzhou University2021-10-01
Impact of Baduanjin Exercise Combined With Rational Emotive Behavior Therapy on Sleep and Mood in Patients With Post-stroke Depression (NCT06245850)Zhengzhou University2021-06-20
A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome. (NCT04999878)Zhengzhou University2021-05-30
Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (NCT03631862)Zhengzhou University2018-09-01

Track Zhengzhou University automatically

Every clearance here is in the API, with alerts when new ones post.